β³ Fetching live dividend data...
Home βΊ Calculator βΊ CZMWY Dividend Calculator 2026
Carl Zeiss Meditec AG Β· OTC
Price: $32.76 Β· Annual div: $0.63/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in CZMWY β $2.12M in 10 years Β· $19.88/month
Carl Zeiss Meditec AG functions as a prominent global medical technology firm, conducting its operations across Germany, other European nations, the United States, and various Asian markets. Its business is organized into two principal divisions: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment provides an array of products and solutions tailored for the diagnosis and therapeutic management of ocular conditions, including specialized systems and essential consumables for cataract, retinal, and refractive surgical procedures. This division serves ophthalmologists, optometrists, and medical and surgical professionals in hospitals and ambulatory surgery centers. The Microsurgery segment focuses on delivering advanced visualization tools vital for intricate surgical interventions, additionally supplying specialized solutions for ear, nose, and throat (ENT), plastic and reconstructive, dental, and spinal surgeries. This segment supports a diverse group of medical practitioners across various disciplines, as well as healthcare institutions. Established in 1846 and headquartered in Jena, Germany, the company operates as a subsidiary of Carl Zeiss AG.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open CZMWY position with:
Real after-tax yield depends on where you live and how you hold CZMWY.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 1.92% | -0.88% | $192 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 1.63% | -1.17% | $163 / yr |
| πΊπΈ US Taxable (20%) | 20% | 1.54% | -1.26% | $154 / yr |
| π¬π§ UK ISA | 0% | 1.92% | -0.88% | $192 / yr |
| π¬π§ UK Taxable | 8.75% | 1.75% | -1.05% | $175 / yr |
| π¨π¦ TFSA | 0% | 1.92% | -0.88% | $192 / yr |
| π¨π¦ CA Taxable | 25% | 1.44% | -1.36% | $144 / yr |
| π¦πΊ Super (pension) | 15% | 1.63% | -1.17% | $163 / yr |
| π¦πΊ AU Taxable | 30% | 1.34% | -1.46% | $134 / yr |
| π©πͺ DE Taxable | 26.375% | 1.41% | -1.39% | $141 / yr |
| π«π· FR Taxable | 30% | 1.34% | -1.46% | $134 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.63/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
CZMWY pays quarterly β 4 times per year. Next ex-div: TBD.
How CZMWY compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CZMWY sourced from FMP /financial-growth endpoint β real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CZMWY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Carl Zeiss Meditec AG (CZMWY) is currently trading at $32.76, 86% below its 52-week high. The current dividend yield is 1.92% based on an annual payout of $0.63 per share.
Carl Zeiss Meditec AG (CZMWY) is a healthcare stock currently trading at $32.76 with a dividend yield of 1.92%. The company pays an annual dividend of $0.63 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, CZMWY has grown its dividend at a compound annual rate of 1.9%.
Auto-generated from live market data. For educational purposes only β not financial advice.
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review β